Tilray Brands, Inc. Accretion Expense
Tilray Brands, Inc. (TLRY) reported Accretion Expense of $7.91 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2026-07-28
- Tilray Brands, Inc. accretion expense for the quarter ending 2026-05-31 was $1.94M, a 8.29% decline year-over-year.
- Tilray Brands, Inc. accretion expense for the quarter ending 2026-02-28 was $2.01M, a 27.22% decline year-over-year.
- Tilray Brands, Inc. accretion expense for the quarter ending 2025-11-30 was $1.99M, a 31.87% decline year-over-year.
- Tilray Brands, Inc. accretion expense for the quarter ending 2025-08-31 was $1.98M, a 35.57% decline year-over-year.
- Tilray Brands, Inc. accretion expense for fiscal 2026 was $7.91M, a 27.15% decline from fiscal 2025.
- Tilray Brands, Inc. accretion expense for fiscal 2025 was $10.86M, a 24.87% decline from fiscal 2024.
- Tilray Brands, Inc. accretion expense for fiscal 2024 was $14.46M, a 275.75% increase from fiscal 2023.
- Tilray Brands, Inc. accretion expense for fiscal 2023 was $3.85M, a 23.68% decline from fiscal 2022.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month | Accretion Expense 9 month | Accretion Expense 12 month |
|---|---|---|---|---|
| 2026-05-31 | $1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $3.95M derived: sum of 2 quarters · filed 2026-07-28 | $5.94M derived: sum of 3 quarters · filed 2026-07-28 | $7.91M 10-K · filed 2026-07-28 |
| 2026-02-28 | $2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-01 | $4.00M derived: sum of 2 quarters · filed 2026-04-01 | $5.98M 10-Q · filed 2026-04-01 | $8.09M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-11-30 | $1.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $3.96M 10-Q · filed 2026-01-08 | $6.08M derived: sum of 3 quarters · filed 2026-07-28 | $8.84M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-08-31 | $1.98M 10-Q · filed 2025-10-09 | $4.09M derived: sum of 2 quarters · filed 2026-07-28 | $6.85M derived: sum of 3 quarters · filed 2026-07-28 | $9.77M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-05-31 | $2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $4.88M derived: sum of 2 quarters · filed 2026-07-28 | $7.80M derived: sum of 3 quarters · filed 2026-07-28 | $10.86M 10-K · filed 2026-07-28 |
| 2025-02-28 | $2.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-01 | $5.68M derived: sum of 2 quarters · filed 2026-04-01 | $8.75M 10-Q · filed 2026-04-01 | $11.75M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-11-30 | $2.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $5.99M 10-Q · filed 2026-01-08 | $8.98M derived: sum of 3 quarters · filed 2026-07-28 | $11.88M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-08-31 | $3.07M 10-Q · filed 2025-10-09 | $6.06M derived: sum of 2 quarters · filed 2026-07-28 | $8.96M derived: sum of 3 quarters · filed 2026-07-28 | $11.98M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-05-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $5.89M derived: sum of 2 quarters · filed 2026-07-28 | $8.91M derived: sum of 3 quarters · filed 2026-07-28 | $14.46M 10-K · filed 2026-07-28 |
| 2024-02-29 | $2.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-08 | $5.92M derived: sum of 2 quarters · filed 2025-04-08 | $11.46M 10-Q · filed 2025-04-08 | $7.37M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-11-30 | $3.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-10 | $8.57M 10-Q · filed 2025-01-10 | $4.47M derived: sum of 3 quarters · filed 2025-07-29 | |
| 2023-08-31 | $5.54M 10-Q · filed 2024-10-10 | $1.45M derived: sum of 2 quarters · filed 2025-07-29 | ||
| 2023-05-31 | -$4.09M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | $3.85M 10-K · filed 2025-07-29 | ||
| 2023-02-28 | $7.94M 10-Q · filed 2024-04-09 | |||
| 2022-05-31 | $5.04M 10-K · filed 2024-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |